Mapping Developmental Lineages to Pinpoint Cells of Origin

You are reading version 1 of this direction, frozen 2026-10-04. The latest version is version 2.

Version 1 of 238 papers43 conceptsfrozen 2026-10-04

For decades, biology classified cells by their appearance and function—their "cell type." However, a growing body of research suggests that a cell’s identity is better defined by its history than its current state. By tracing the "family tree" of cell divisions, researchers are discovering that the specific progenitor cell from which a tissue or tumor arises—the cell of origin—dictates its behavior, its connectivity, and its vulnerability to disease.

The Predictive Power of Mitotic History

In traditional models, we assume that all cells of a certain type (like a neuron or a fibroblast) will behave similarly. But Jordan K. Matelsky, Brock A. Wester, and Konrad Kording demonstrated in Cell lineage predicts neural connectivity beyond cell type that a cell's mitotic history—the specific sequence of divisions that created it—is actually a better predictor of how it will wire itself into a neural circuit than its "cell type" label.

This shift from static labels to dynamic lineages is crucial because many diseases do not target a "type" of cell, but rather a specific "moment" in a lineage. For example, in the human breast, Vasudeva Bhat and colleagues identified a previously unknown Basal-like Luminal Progenitor (BLP). This intermediate cell acts as a bridge in the mammary hierarchy, and identifying it provides a specific target for understanding how aggressive "basal-like" breast cancers begin.

Why the Cell of Origin Matters for Cancer

In oncology, the "cell of origin" is the healthy cell that acquires the first oncogenic mutations. Identifying this cell is not just an academic exercise; it explains why tumors that look similar under a microscope can respond differently to treatment.

In medulloblastoma, Giles Robinson and Matthew Parker showed that novel mutations target distinct subgroups of the disease. By tracing these back to specific progenitor populations, researchers like Paul A. Northcott have been able to "crack the code" of mysterious tumor subtypes, revealing mechanisms like enhancer hijacking that are unique to specific developmental lineages.

Similarly, Xiaojun Ren and Yiming Zhang used single-cell transcriptomics to prove that endometrioid endometrial carcinoma originates specifically from unciliated glandular epithelial cells, rather than the surrounding stroma. This precision allows for the development of early-detection biomarkers that target the exact population undergoing malignant transformation.

Resolving Debates in Fibrosis and Aging

The search for the cell of origin also resolves long-standing debates in regenerative medicine. For years, scientists argued over which cells drive the scarring (fibrosis) seen in diseases like systemic sclerosis. While some suggested that fat cells or pericytes were the culprits, Tracy Tabib and Mengqi Huang identified a specific population of SFRP2+ fibroblast progenitors as the primary source of myofibroblasts in human skin.

In the context of aging, Yaru Su and colleagues challenged the idea that immunosuppressive cells emerge from "immature" progenitors. Instead, their work on myeloid-derived suppressor cells suggests these cells actually emerge from mature neutrophils and monocytes that have undergone a late-stage functional shift.

Tools for Mapping the Unseen

How do we find these cells when they are often rare or transient? The field has moved toward "multi-omic" atlases and lineage recording:

  1. Single-Cell Atlases: Projects like B-rex, developed by Núria Planell and Xabier Martinez-de-Morentin, map the regulatory landscape of B-cell development to find the "inflection points" where healthy maturation turns into leukemia.
  2. Molecular Scarring: Systems like iTracer, introduced by Zhisong He and Ashley Maynard, use CRISPR to leave genetic "scars" in developing organoids. These scars act as barcodes, allowing researchers to reconstruct the entire family tree of a complex 3D tissue.
  3. Functional Markers: Identifying the "apex" of a hierarchy requires better markers. Danilo Pellin and Samuel L. Wolock identified CD164 as a superior marker for the most primitive blood stem cells, providing a more stable target for gene therapies than previous industry standards.

By understanding the lineage, we move from treating the symptoms of a "cell type" to intervening at the very source of the "cell of origin."

Papers in this version

History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 31 papers
  2. Version 1 · 2026-10-04 · 38 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_cell_of_origin_identification_98fad040,
  title = {cell of origin identification},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/cell-of-origin-identification/rdr_98fad040216c4cd7885a5a164dde4a42},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-22},
}

This exact version (version 1, frozen text):

@misc{lacuna_mapping_developmental_lineages_to_pinpoi_98fad040_v1,
  title = {Mapping Developmental Lineages to Pinpoint Cells of Origin},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/mapping-developmental-lineages-to-pinpoint-cells-of-origin/rdr_98fad040216c4cd7885a5a164dde4a42/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-22},
}